Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for PAVmed Inc. (PAVM : NSDQ)
 
 • Company Description   
PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City.

Number of Employees: 89

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.03 Daily Weekly Monthly
20 Day Moving Average: 2,419,489 shares
Shares Outstanding: 87.96 (millions)
Market Capitalization: $90.60 (millions)
Beta: 0.22
52 Week High: $9.70
52 Week Low: $0.94
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.83% 6.07%
12 Week -30.41% -24.78%
Year To Date -58.13% -50.41%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
ONE GRAND CENTRAL PLACE 60 E. 42ND STREET SUITE 4600
-
NEW YORK,NY 10165
USA
ph: 212-949-4319
fax: -
pavmed@lavoiehealthscience.com http://www.pavmed.com
 
 • General Corporate Information   
Officers
Lishan Aklog - Chief Executive Officer and Chairman of the Board
Michael J. Glennon - Vice Chairman
Dennis M. McGrath - President and Chief Financial Officer
Debra J. White - Director
James L. Cox - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 70387R106
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 87.96
Most Recent Split Date: (:1)
Beta: 0.22
Market Capitalization: $90.60 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.89 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.18
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -75.00%
vs. Previous Quarter: 6.67%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -37.00%
ROE
03/31/22 - -86.63
12/31/21 - -76.84
09/30/21 - -108.12
ROA
03/31/22 - -73.00
12/31/21 - -65.47
09/30/21 - -76.90
Current Ratio
03/31/22 - -
12/31/21 - 10.93
09/30/21 - 5.38
Quick Ratio
03/31/22 - -
12/31/21 - 10.93
09/30/21 - 5.38
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -11,225.20
09/30/21 - -22,853.50
Book Value
03/31/22 - -
12/31/21 - 0.88
09/30/21 - 0.39
Inventory Turnover
03/31/22 - -
12/31/21 - 46.80
09/30/21 - 11.52
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©